glutathione in ovarian cancer a double-edged sword Frontiers Reactive oxygen species: Janus-faced molecules
Reactive oxygen species: Janus faced molecules in the era of modern cancer therapy Journal for ImmunoTherapy of Cancer Frontiers The strategic breakdown: CHAC enzymes as regulators of glutathione homeostasis and disease implications Frontiers Targeting ferroptosis: a promising avenue for ovarian cancer treatment Lipocalin 2: a double edged sword in cellular ferroptosis Cell Biology and Toxicology Springer Nature Link
Pay in 4 interest-free payments of $6.74 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



